Brian Ball, Eytan M. Stein. Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?. haematol [Internet]. 2019Jul.31 [cited 2024Nov.22];104(8):1521-3. Available from: https://haematologica.org/article/view/9000